Skip to main content
Glama

Ipquery

by io.github.pipeworx-io

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "ticker"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.4/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare read-only/idempotent, and the description adds substantial behavior beyond them: empty sections are 'a real "no data", not a bug', private companies return resolved:false with an explicit notes line rather than a bare failure, and the FDA section says 'a company with only small-molecule/generic drugs will show none here, that is expected, not a failure'. Also discloses the GDELT→GNews fallback and source-failure semantics via sources_used/sources_failed.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Purpose and trigger phrases are front-loaded, followed by routing, return spec, and edge-case semantics in logical order. It is long, but every sentence earns its place given there is no output schema to carry the return-format burden. The dense enumeration of sources and fields is somewhat heavy, though justifiable.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex multi-source tool with no output schema, the description carries everything an agent needs: the exact fan-out sources, per-source return fields (including pipeworx:// URIs for filings), the meaning of sources_used/sources_failed, accepted input shapes, and both failure modes (private company, empty sections). Nothing an agent needs to invoke or interpret this correctly is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so both parameters are already fully documented. The description restates the same accepted shapes (ticker, zero-padded CIK, name) and adds a modest edge-case note about private-company resolution, which is genuinely useful but only marginally extends the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource: 'full cross-source profile of a US public company in ONE parallel call,' reinforced by seven concrete trigger phrases ('brief me on Tesla', 'what does Apple do', etc.). The scope is unambiguous and the 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups' line distinguishes it from more granular lookup tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives an explicit routing rule — 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view' — plus trigger phrases that signal the right intent. It does not explicitly disambiguate from sibling research tools like deep_research or resolve_entity, so the when-not-to-use guidance is not exhaustive.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Ipquery toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Many tools are clearly distinct, but the existence of multiple ask_pipeworx variants (standard, beta, grounded) and the overlapping check_risk/lookup_ip tools create meaningful selection ambiguity. Description differentiation helps but doesn't fully resolve it.

Naming Consistency3/5

All names use snake_case, but conventions vary between verb-noun (lookup_ip, compare_entities), noun phrases (entity_profile, recent_alerts), and domain-prefixed names (polymarket_edges, pipeworx_trending). It's readable but not a consistent pattern.

Tool Count2/5

At 33 tools the surface is large, with duplicated ask_pipeworx variants, a modest IP lookup core, and a large number of meta/management tools (memory, subscriptions, onboarding, feedback). Even with a broad scope this feels overloaded, and it is well above the 25+ threshold.

Completeness4/5

The query domain is well covered: entity profiles, comparison, claim validation, deep research, changes, plus memory and subscription management. Minor gaps exist (no direct subscription update, no raw citation fetch utility), but agents can work around them.

Resources